Matthew Mcgraw

NPI1477809176

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$2,891.51
from 2 payments in the last 6 years

Total Cash or Cash Equivalent

$2,880.00
from 1 payments in the last 6 years

Total In-kind Items & Services

$11.51
from 1 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
06/15/2021 General (Non-Research) Cash or cash equivalent Consulting Fee $2880.00 Details
Payment from Boehringer Ingelheim Pharmaceuticals, Inc.
Payment Record ID 763750524
09/21/2018 General (Non-Research) In-kind items and services Education $11.51 Details
Payment from Vertex Pharmaceuticals Incorporated
Payment Record ID 585550967